纤维修饰的康布查茶对健康人群肠道微生物群的影响:随机对照试验 (RCT)
Beatriz Arce-López1, Guadalupe X Bazan1, Susana Molina1
1GENYAL Platform, IMDEA Food, CEI UAM+CSIC, Carretera de Cantoblanco, 8, 28049, Madrid, Spain.
Current research in food science
|July 21, 2025
概括
富含纤维的kombucha茶显示出通过增加有益的Bifidobacterium和减少Ruminococcus扭矩来改善甘油三水平和肠道健康的潜力. 需要进一步的试验来确认这些对代谢和肠道健康的积极影响.
科学领域:
- 营养科学 营养科学
- 微生物学 微生物学
- 功能性食品 功能性食品
背景情况:
- 功能性食物是治疗慢性疾病的关键.
- 肠道微生物群研究提供了对健康和疾病相互作用的见解.
研究的目的:
- 评估富含纤维的康布查茶对生物化学标记物的影响.
- 评估健康成年人肠道微生物群组成的变化.
主要方法:
- 随机,双盲,并行营养干预试验.随机,双盲,并行营养干预试验.
- 60名健康参与者在6周内饮用了康布查或对照饮料.
- 16S rDNA测序分析了肠道微生物群的组成.
主要成果:
- 富含纤维的kombucha显著影响了甘油三水平 (p=0.031).
- 观察到有益的Bifidobacterium的丰度增加.
- 减少Ruminococcus扭矩的水平,与IBD相关.
结论:
- 富含纤维的kombucha显示出调节甘油三和改善肠道微生物群的潜力.
- 这种饮料可能对健康个体的代谢和肠道健康有益.
- 建议进行进一步的随机对照试验以验证研究结果.
相关概念视频
Bacterial Flora of the Large Intestine
651
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
651
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
203
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
203
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
320
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
320
Drugs for Treatment of Diarrhea-Predominant IBS
301
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
301
Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Drugs for Treatment of Constipation-Predominant IBS
342
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
342


